ENRIQUE GERMÁN
RAYA ÁLVAREZ
PROFESOR TITULAR DE UNIVERSIDAD
![Foto de ENRIQUE GERMÁN](/img/nophoto.png)
![Foto de Hospital Universitario Marqués de Valdecilla](/img/noimage_org.png)
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Marqués de Valdecilla (21)
2024
-
Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants
npj Genomic Medicine, Vol. 9, Núm. 1
2023
-
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome
Journal of Autoimmunity
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
2022
-
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review
Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436
2021
-
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
Nature Communications, Vol. 12, Núm. 1
-
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
Scientific Reports, Vol. 11, Núm. 1
-
Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice
Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558
2020
-
IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
Scientific Reports, Vol. 10, Núm. 1
2015
2014
-
Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82
-
Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors
Joint Bone Spine, Vol. 81, Núm. 2, pp. 164-168
-
Cardiovascular risk assessment in rheumatoid arthritis: Impact of the EULAR recommendations on a national calibrated score risk index
Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 237-242
-
Évaluation du risque cardiovasculaire selon l'indice SCORE national calibré chez les patients atteints de rhumatisme psoriasique sans maladie cardiovasculaire clinique évidente ni de facteurs de risque classiques d'athérosclérose
Revue du Rhumatisme (Edition Francaise), Vol. 81, Núm. 2, pp. 154-158
2013
-
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886
-
Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease
Human Immunology, Vol. 74, Núm. 2, pp. 230-233
2012
-
Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: The LESIMAB study
Lupus, Vol. 21, Núm. 10, pp. 1063-1076
-
NPSR1 gene is associated with reduced risk of rheumatoid arthritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1166-1170
2011
-
Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region
Journal of Rheumatology, Vol. 38, Núm. 11, pp. 2290-2296
-
No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data
Human Immunology, Vol. 72, Núm. 9, pp. 779-782
-
The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples
Arthritis and Rheumatism, Vol. 63, Núm. 2, pp. 365-372